Samsung Medison launched its premium obstetrics and gynecology (OB/GYN) ultrasound diagnostic system, the HERA Z10. Alongside the flagship HERA Z20, the new system officially completes the HERA Z Series (Z20 & Z10) lineup.
With global trends showing an increase in maternal age and pregnancy-related complications, precision imaging for prenatal diagnostics and rapid clinical decision-making have become increasingly vital. As a result, women’s health diagnostic systems are evolving beyond basic fetal evaluations to encompass early complication prediction, maternal health assessments, and holistic wellness.
Aligning with these global clinical needs, Samsung Medison showcased the HERA Z Series at the 34th International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) World Congress held in London from September 4 to 7.
Interactive Experiences and Digital Synergy at ISUOG
At the ISUOG Congress, Samsung Medison hosted interactive experience zones highlighting the core value proposition of the HERA Z Series. Under the theme “ART OF ULTRASOUND,” an AI digital art exhibition reinterpreting fetal ultrasound images drew strong interest from attendees. Additionally, Samsung Medison demonstrated an integrated digital solution using Galaxy Tab devices, allowing clinicians and mothers to seamlessly monitor fetal growth records throughout the pregnancy journey.
“The launch of the HERA Z10 is more than just an addition to our product lineup; it represents a major milestone in extending the distinctive clinical value of the HERA Z Series to a wider range of healthcare settings,” said Jihyun Kim, Head of CX Team at Samsung Medison. “By leveraging premium imaging technology and unparalleled AI workflows, we remain committed to meeting diverse clinical needs and driving brand innovation so that healthcare professionals worldwide can select custom-fit solutions optimized for their unique practice environments.”
Leave a comment